首页> 外文期刊>Journal of Clinical Pathology >TCR-Vβ flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia
【24h】

TCR-Vβ flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia

机译:TCR-Vβ流式细胞仪分析外周血以评估T细胞大颗粒淋巴细胞白血病患者的克隆性和疾病负担

获取原文
获取原文并翻译 | 示例
           

摘要

Aims T cell large granular lymphocytes (T-LGLs) are commonly increased in reactive conditions as well as T-LGL leukaemia. This differential diagnosis often requires a combined assessment of clonality and tumour burden. In this study we assessed the utility of flow cytometric (FC) analysis of T cell receptor β chain variable region (TCR-Vβ) expression by using 24 antibodies reactive to 70% of the TCR-Vβ repertoire. Methods Analyses were performed on peripheral blood samples obtained from 20 patients with a confirmed diagnosis of T-LGL leukaemia and 18 patients without known T cell lymphoproliferative diseases. Results The results were compared with TCR gene rearrangement status assessed by PCR. By FC analysis, 19/20 T-LGL leukaemia cases were CD3 + CD8+ and one case was CD3 + CD4 + . All the cases demonstrated at least one immunophenotypic aberration, with altered CD5 expression being most frequent. Abnormal Vβ expression was detected by FC in 19 of 20 (95%) T-LGL leukaemia cases, but in none of the controls; this showed 100% concordance with TCR gene rearrangement studies. In addition to establishing clonality, FC Vβ analysis enables calculation of absolute numbers of clonal T cells; this is important in monitoring tumour burden after treatment. Conclusions It is concluded that FC Vβ analysis is a fast, reliable and quantitative method that can simultaneously assess T-LGL leukaemia clonality and tumour burden.
机译:目的T细胞大颗粒淋巴细胞(T-LGLs)通常在反应性疾病以及T-LGL白血病中增加。这种鉴别诊断通常需要对克隆性和肿瘤负担进行综合评估。在这项研究中,我们通过使用对70%TCR-Vβ组成成分有反应性的24种抗体,评估了T细胞受体β链可变区(TCR-Vβ)表达的流式细胞术(FC)分析的实用性。方法对20例确诊为T-LGL白血病的患者和18例无已知T细胞淋巴增生性疾病的患者进行外周血分析。结果将结果与通过PCR评估的TCR基因重排状态进行比较。通过FC分析,19/20 T-LGL白血病病例为CD3 + CD8 +,1例为CD3 + CD4 +。所有病例均显示至少一种免疫表型畸变,其中CD5表达改变最为常见。在20例(95%)T-LGL白血病病例中有19例通过FC检测到Vβ表达异常,但在所有对照组中均未检测到。这表明与TCR基因重排研究100%一致。除了建立克隆性外,FCVβ分析还可以计算克隆T细胞的绝对数量。这对于监测治疗后的肿瘤负荷很重要。结论结论是,FCVβ分析是一种可以同时评估T-LGL白血病克隆性和肿瘤负担的快速,可靠和定量的方法。

著录项

  • 来源
    《Journal of Clinical Pathology》 |2010年第2期|141-146|共6页
  • 作者单位

    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;

    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;

    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;

    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;

    Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号